12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Copaxone glatiramer acetate regulatory update

Teva disclosed on a conference call to discuss its 1Q13 earnings that it submitted an sNDA to FDA in March to add a...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >